Cargando…
Urinary Metabolomics Validates Metabolic Differentiation Between Renal Cell Carcinoma Stages and Reveals a Unique Metabolic Profile for Oncocytomas
Renal cell carcinoma (RCC) is a heterogeneous malignancy which often develops and progresses asymptomatically. Benign oncocytomas are morphologically similar to malignant chromophobe RCC and distinguishing between these two forms on cross-sectional imaging remains a challenge. Therefore, RCC-specifi...
Autores principales: | Falegan, Oluyemi S., Arnold Egloff, Shanna A., Zijlstra, Andries, Hyndman, M. Eric, Vogel, Hans J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724101/ https://www.ncbi.nlm.nih.gov/pubmed/31344778 http://dx.doi.org/10.3390/metabo9080155 |
Ejemplares similares
-
Urine and Serum Metabolomics Analyses May Distinguish between Stages of Renal Cell Carcinoma
por: Falegan, Oluyemi S., et al.
Publicado: (2017) -
The Genomic Landscape of Renal Oncocytoma Identifies a Metabolic Barrier to Tumorigenesis
por: Joshi, Shilpy, et al.
Publicado: (2015) -
Giant renal oncocytoma
por: Shakarchi, Julien Al, et al.
Publicado: (2015) -
Early loss of mitochondrial complex I and rewiring of glutathione metabolism in renal oncocytoma
por: Gopal, Raj K., et al.
Publicado: (2018) -
MicroRNAs as Urinary Biomarker for Oncocytoma
por: von Brandenstein, Melanie, et al.
Publicado: (2018)